GL1X · GenesisL1 explorer

UniProt Q9UHD2

Serine/threonine-protein kinase TBK1 (Q9UHD2)

Serine/threonine-protein kinase TBK1 (UniProt Q9UHD2), EC 2.7.11.1: 43 experimental structures on GenesisL1, 11 ligands bound, 20 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
Q9UHD2
Protein
Serine/threonine-protein kinase TBK1
EC
2.7.11.1
Experimental structures
43
Predicted models
0
Ligands
11
Pockets
20 · 3 records with a druggable one

Structures

43 records of Q9UHD2 in the MolNFT archive: 43 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
4EFOCrystal structure of the ubiquitin-like domain of human TBK1x-ray diffractionA, B——
4EFOCrystal structure of the ubiquitin-like domain of human TBK1x-ray diffractionA, B——
4EUTStructure of BX-795 Complexed with Unphosphorylated Human TBK1 Kinase-ULD Domainx-ray diffractionA, B——
4EUTStructure of bx-795 complexed with unphosphorylated human TBK1 kinase- uld domainx-ray diffractionA, B——
4EUUStructure of BX-795 Complexed with Human TBK1 Kinase Domain Phosphorylated on Ser172x-ray diffractionA, B——
4EUUStructure of bx-795 complexed with human TBK1 kinase domain phosphorylated on SER172x-ray diffractionA, B——
4IM0Structure of Tank-Binding Kinase 1x-ray diffractionA——
4IM0Structure of tank-binding kinase 1x-ray diffractionA——
4IM2Structure of Tank-Binding Kinase 1x-ray diffractionA——
4IM2Structure of tank-binding kinase 1x-ray diffractionA——
4IM3Structure of Tank-Binding Kinase 1x-ray diffractionA——
4IM3Structure of tank-binding kinase 1x-ray diffractionA——
4IW0Crystal structure and mechanism of activation of TBK1x-ray diffractionA——
4IW0Crystal structure and mechanism of activation of TBK1x-ray diffractionA——
4IWOCrystal structure and mechanism of activation of TBK1x-ray diffractionA——
4IWOCrystal structure and mechanism of activation of TBK1x-ray diffractionA——
4IWPCrystal structure and mechanism of activation of TBK1x-ray diffractionA——
4IWPCrystal structure and mechanism of activation of TBK1x-ray diffractionA——
4IWQCrystal structure and mechanism of activation of TBK1x-ray diffractionA——
4IWQCrystal structure and mechanism of activation of TBK1x-ray diffractionA——
5EOACrystal structure of OPTN E50K mutant and TBK1 complexx-ray diffractionC, D——
5EOACrystal structure of optn E50K mutant and TBK1 complexx-ray diffractionC, D——
5EOFCrystal structure of OPTN NTD and TBK1 CTD complexx-ray diffractionC, D——
5EOFCrystal structure of optn ntd and TBK1 ctd complexx-ray diffractionC, D——
5EP6The crystal structure of NAP1 in complex with TBK1x-ray diffractionB, D——
5EP6The crystal structure of NAP1 in complex with TBK1x-ray diffractionB, D——
5W5VTBK1 co-crystal structure with amlexanoxx-ray diffractionAANW—
6BNYTBK1 in complex with tetrazole analog of amlexanoxx-ray diffractionAE0M8 (best 0.71)
6BNYTBK1 in complex with tetrazole analog of amlexanoxx-ray diffractionAE0M—
6BODTBK1 in complex with ethyl ester analog of amlexanoxx-ray diffractionAE0P—
6BOETBK1 in complex with amide-coupled tetrazole analog of amlexanoxx-ray diffractionAE0S6 (best 0.70)
6BOETBK1 in complex with amide-coupled tetrazole analog of amlexanoxx-ray diffractionAE0S—
6CQ0TBK1 in complex with dimethyl amino analog of amlexanoxx-ray diffractionAF8M—
6CQ4TBK1 in complex with cyclohexyl analog of amlexanoxx-ray diffractionAF8P—
6CQ5TBK1 in complex with sulfone analog of amlexanoxx-ray diffractionAF8S—
6NT9Cryo-EM structure of the complex between human TBK1 and chicken STINGelectron microscopyA, B——
6NT9Cryo-EM structure of the complex between human TBK1 and chicken stingelectron microscopyA, B——
6O8BCrystal structure of sting ctd in complex with TBK1x-ray diffractionA, BBX7—
6RSRTBK1 in complex with compound 2x-ray diffractionAKHT—
6RSTTBK1 in complex with inhibitor compound 24x-ray diffractionAKHQ6 (best 0.72)
6RSTTBK1 in complex with inhibitor compound 24x-ray diffractionAKHQ—
6RSUTBK1 in complex with inhibitor compound 35x-ray diffractionAKJB—
Q9UHD2AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase TBK1 (Q9UHD2)———

Ligands

  • E0M · 2-amino-7-(propan-2-yl)-3-(1H-tetrazol-5-yl)-5H-[1]benzopyrano[2,3-b]pyridin-5-one · in 2 records
  • E0S · 2-amino-5-oxo-7-(propan-2-yl)-N-(1H-tetrazol-5-yl)-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxamide · in 2 records
  • KHQ · 1-[4-[(1~{R})-1-[2-[[5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1~{H}-benzimidazol-2-yl]amino]pyridin-4-yl]ethyl]piperazin-1-yl]-3,3,3-tris(fluoranyl)propan-1-one · in 2 records
  • ANW · 2-amino-7-(1-methylethyl)-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid · in 1 record
  • BX7 · N-(3-{[5-iodo-4-({3-[(thiophen-2-ylcarbonyl) amino]propyl}amino)pyrimidin-2-yl]amino}phenyl) pyrrolidine-1-carboxamide · in 1 record
  • E0P · Ethyl 2-amino-5-oxo-7-(propan-2-yl)-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylate · in 1 record
  • F8M · 2-amino-7-[3-(dimethylamino)propyl]-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid · in 1 record
  • F8P · 2-amino-7-(4,4-difluorocyclohexyl)-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid · in 1 record
  • F8S · 2-amino-7-(1,1-dioxo-1lambda~6~-thian-4-yl)-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid · in 1 record
  • KHT · ~{N}-(cyclopropen-1-ylmethyl)-2-[[4-[[4-[3,3,3-tris(fluoranyl)propanoyl]piperazin-1-yl]methyl]pyridin-2-yl]amino]-1~{H}-benzimidazole-5-carboxamide · in 1 record
  • KJB · 3,3,3-tris(fluoranyl)-1-[4-[(1~{R})-1-[2-[[(2~{S})-5-(5-propan-2-yloxypyrimidin-4-yl)-2,3-dihydro-1~{H}-benzimidazol-2-yl]amino]pyridin-4-yl]ethyl]piperazin-1-yl]propan-1-one · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.